Literature DB >> 20598957

Incidence and identification of intrathecal baclofen catheter malfunction.

Eric M Dvorak1, John R McGuire, Mary Elizabeth S Nelson.   

Abstract

OBJECTIVE: A retrospective chart review was undertaken of cases of intrathecal baclofen (ITB) pump/catheter malfunction and the diagnostic tests performed to identify the problem. An internal review was performed to develop a diagnostic flow chart to have a systematic method for identifying ITB pump and catheter complications.
DESIGN: Retrospective chart review.
SETTING: Tertiary care hospital. PARTICIPANTS: A total of 167 adult patients currently followed in outpatient clinic with intractable spasticity and ITB pump implanted between January 1994 and May 2009.
INTERVENTIONS: None. MAIN OUTCOME MEASURES: Catheter malfunction was identified either by anterior/posterior and lateral thoracic/lumbar radiographs, fluoroscopic guided side port access, contrast agent injection followed by CT (fluoro/CT) scan, or indium radionuclide studies.
RESULTS: During the study period, 33 patients had 37 catheter revisions. Radiographs were obtained in all cases; fluoro/CT studies in 22, and indium studies in 6. Four cases had both fluoro/CT and indium studies. A total of 13 cases (35.1%) were diagnosed with radiographs; 9 cases (24.3%) were diagnosed by inability to withdraw cerebral spinal fluid from the side port; 13 cases (35.1%) were diagnosed with fluoro/CT studies; and 2 cases (5.4%) were diagnosed with indium studies. Fluoro/CT studies demonstrated subdural catheter location in 7 cases. A total of 2 of 4 cases with both fluoro/CT and indium studies had normal-appearing indium scans and an abnormal fluoro/CT study confirming subdural catheter placement.
CONCLUSIONS: On the basis of an internal review of the diagnostic studies used to identify patients with suspected ITB pump/catheter malfunction, a troubleshooting flow chart was developed. Timely identification and correction of potential ITB complications could improve the clinical effectiveness of ITB and may reduce unnecessary health-care costs.
Copyright © 2010 American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20598957     DOI: 10.1016/j.pmrj.2010.01.016

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.298


  7 in total

1.  Managing loss of intrathecal baclofen efficacy: Review of the literature and proposed troubleshooting algorithm.

Authors:  Aaron Boster; Jacqueline Nicholas; Mary Pat Bartoszek; Colleen O'Connell; Chima Oluigbo
Journal:  Neurol Clin Pract       Date:  2014-04

2.  Evaluation of usefulness of scintigraphic imaging in diagnosis of intrathecal drug delivery system malfunction - a preliminary report.

Authors:  Jacek Teodorczyk; Tomasz Szmuda; Mariusz Siemiński; Piotr Lass; Paweł Słoniewski
Journal:  Pol J Radiol       Date:  2013-07

3.  Minimally invasive repair of a pseudomeningocele caused by a sheared intrathecal catheter following implantation of a drug delivery system.

Authors:  S Raju; P O Champagne; L Walsh; Daniel J Denis
Journal:  Surg Neurol Int       Date:  2017-12-06

4.  Low-Dose Computed Tomography With Two- and Three-Dimensional Postprocessing as an Alternative to Plain Radiography for Intrathecal Catheter Visualization: A Phantom Pilot Study.

Authors:  Elmar M Delhaas; Aad van der Lugt
Journal:  Neuromodulation       Date:  2019-05-14

5.  Catheter Access Port (Computed Tomography) Myelography in Intrathecal Drug Delivery Troubleshooting: A Case Series of 70 Procedures.

Authors:  Elmar M Delhaas; Biswadjiet S Harhangi; Sander P G Frankema; Frank J P M Huygen; Aad van der Lugt
Journal:  Neuromodulation       Date:  2020-04-08

6.  Isotopic Scintigraphy in Intrathecal Drug Delivery Failure: A Single-Institution Case Series.

Authors:  Elmar M Delhaas; Daniëlle M E van Assema; Alida C Fröberg; Ben G J C Zwezerijnen; Biswadjiet S Harhangi; Sander P G Frankema; Frank J P M Huygen; Aad van der Lugt
Journal:  Neuromodulation       Date:  2020-09-18

7.  European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A.

Authors:  Bo Biering-Soerensen; Valerie Stevenson; Djamel Bensmail; Klemen Grabljevec; Mercedes Martínez Moreno; Elke Pucks-Faes; Joerg Wissel; Mauro Zampolini
Journal:  J Rehabil Med       Date:  2022-01-03       Impact factor: 2.912

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.